Overview

Price




Price




Daxor Corporation (NYSE: DXR) is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100® (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms. The BVA technology enhances hospital performance metrics in a broad range of surgical and medical conditions, including heart failure and critical care, by informing treatment strategies, resulting in significantly improved multiple measures of patient outcomes. Daxor’s mission is to advance healthcare by enabling optimal fluid management with blood volume analysis. Daxor’s vision is optimal blood volume for all.


 Price History

 Useful Links

 Company Profile

107 Meco Lane,
Oak Ridge, TN 37830

212-330-8500

info@www.daxor.com


News

Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19

Watch Daxor CEO, Michael Feldschuh, Discuss How BVA-100 Technology is Joining to Fight COVID-19


In the Spotlight

BioSpace:

Update on the Novel Coronavirus

MPO Magazine:

FDA-Cleared Blood Test Used to Guide COVID-19 Treatment

TechNetworks:

Maintaining Optimal Blood Volume in COVID-19 Patients

BioTuesdays:

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

MedGadget:

Blood Volume Analysis Using The BVA-100: Interview with Michael Feldschuh, Daxor CEO

BioWorld:

Blood Volume Assessment Study to use Daxor Device

Outsourcing-Pharma

Daxor Research Battles Military Injuries

Healio:

Blood Volume Analysis May Help Guide Treatment in HF Hospitalization at Low Cost

Technology
Networks:

Daxor Corporation Announces Phase-Two US Air Force Contract Award for Point-Of-Care Optical Blood Volume Analyzer

BioSpace:

Update on the Novel Coronavirus

MPO Magazine:

FDA-Cleared Blood Test Used to Guide COVID-19 Treatment

TechNetworks:

Maintaining Optimal Blood Volume in COVID-19 Patients

BioTuesdays:

Daxor targeting blood volume analysis to reduce mortality and ventilator use in ICU

MedGadget:

Blood Volume Analysis Using The BVA-100: Interview with Michael Feldschuh, Daxor CEO

BioWorld:

Blood Volume Assessment Study to use Daxor Device

Outsourcing-Pharma

Daxor Research Battles Military Injuries

Healio:

Blood Volume Analysis May Help Guide Treatment in HF Hospitalization at Low Cost

Technology
Networks:

Daxor Corporation Announces Phase-Two US Air Force Contract Award for Point-Of-Care Optical Blood Volume Analyzer

key contacts

Investor Relations

Bret Shapiro
CORE IR
377 Oak Street
Garden City, NY 11530
Phone: 516-222-2560
E-mail: brets@coreir.com
www.coreir.com

Transfer Agent

Continental Stock Transfer
1 State Street, 30th Floor
New York, NY 10004
Phone: 212-509-4000
E-mail: cstmail@continentalstock.com
www.continentalstock.com

Auditors

Withum Smith & Brown
1411 Broadway, 9th Floor
New York, NY 10018
Phone: 212-751-9100
Fax: 212-750-3262
E-mail: mstallone@withum.com
www.withum.com

Corporate Counsel

Peter Fetzer
Foley & Lardner LLP
777 East Wisconsin Avenue
Milwaukee, Wisconsin 53202
Phone: 414-271-2400
Fax: 414-297-4900
www.foley.com

key contacts

Partner With the Dedicated Leader in BVA

As the pioneer in blood volume analysis, Daxor provides education and the resources needed to ensure easy onboarding along with continuing support to drive maximum value from your BVA system throughout your facility. With a long-standing commitment to improving care and numerous studies validating our technology, Daxor is completely focused on advancing healthcare by enabling optimal fluid management with blood volume analysis. Our vision is optimal blood volume for all.

Volume is Vital. End the Debate With Daxor.

Call us at 865-425-0555.

 

Daxor Corporation is the global leader in blood volume measurement technology focused on blood volume testing innovation. We developed and market the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms for use in a broad range of medical and surgical conditions.

Daxor Corporation – 107 Meco Lane, Oak Ridge, TN 37830
Phone: 212-330-8500 | Fax: 516-828-4772
info@daxor.com | daxor.com

ISO 13485 Certified

Made in the USA.

COPYRIGHT 2021 © DAXOR CORPORATION – ALL RIGHTS RESERVED.